Targeted PET/CT tracer improves early prediction of treatment response in rheumatoid arthritis patients
treatment'>Targeted PET/CT tracer improves early prediction of treatment response in rheumatoid arthritis patients is drawing significant interest across the industry.
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Warmer US Weather Weighs on Nat-Gas Demand and Prices
- Rita Finance and Leasing Limited Signs Strategic MOU to Acquire 45% Stake in Aaquaria Fincart
- Canton senior gets overtime victory
- Jennifer Garner refuses to promise her children she won't have a facelift
Source: Original →